The Life Sciences Virtual Investor Forum, scheduled for March 11 and 12, 2026, represents a significant opportunity for public companies across therapeutic and healthcare markets to connect directly with a global audience of individual and institutional investors. This event, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, is highlighted as a Featured Conference by B2i Digital, Inc., which serves as the Official Marketing Partner. The forum's importance lies in its structured approach to investor engagement, which is critical for life sciences companies that often require substantial capital for research, development, and commercialization.
Participating companies will deliver live, interactive online presentations followed by real-time question-and-answer sessions. Investors can also request one-on-one meetings with management teams through the VIC platform, providing a level of access that is typically difficult to achieve outside of major financial conferences. After the event, presentation replays will be available for on-demand viewing, extending the visibility and engagement potential for companies long after the live sessions conclude. This model addresses a key challenge in the capital markets: efficiently matching investors with compelling investment opportunities in the life sciences sector, which includes biotechnology, pharmaceuticals, medical devices, and digital health.
The list of presenting companies underscores the forum's broad reach across the life sciences industry. On March 11, presentations include SeaStar Medical Holding Corporation, Nasus Pharma Ltd., Tonix Pharmaceuticals Holding Corp., and Jupiter Neurosciences, Inc. The March 12 schedule features Bora Pharmaceuticals, Prostatype Genomics AB, MetaVia Inc., Phio Pharmaceuticals Corp., Avicanna Inc., EMVision Medical Devices Ltd., Aethlon Medical, Dyadic International, Jaguar Health, Inc., Beyond Air, Inc., Cadrenal Therapeutics, Inc., and Amplia Therapeutics Ltd. Among these, Jupiter Neurosciences, Inc. and Phio Pharmaceuticals Corp. are specifically noted as B2i Digital Featured Companies, indicating a heightened marketing partnership.
For investors, the forum offers a consolidated venue to evaluate a diverse array of public life sciences companies without the logistical and cost barriers of physical travel. The ability to interact directly with management teams and access presentation materials on demand enhances due diligence and informed decision-making. For the presenting companies, the forum provides a platform to articulate their value propositions, clinical progress, and market strategies to a targeted investor audience, which is essential for raising capital and building shareholder bases. The partnership with B2i Digital, which supports awareness through digital marketing and social media promotion, amplifies this reach. Virtual Investor Conferences, a property of OTC Markets Group Inc., facilitates participation from companies listed on major exchanges including NYSE, Nasdaq, TSX, CSE, ASX, and OTC Markets, ensuring a wide spectrum of investment opportunities.
The implications of this event extend beyond the immediate presentations. By fostering connections between companies and investors, the forum contributes to the overall liquidity and efficiency of the capital markets for life sciences. This is particularly important for smaller-cap companies that may lack the resources for extensive investor relations campaigns. The digital format, proven effective in recent years, democratizes access, allowing global participation. For comprehensive profiles of participating companies and to register, interested parties can visit the Virtual Investor Conferences registration page. Additional details about the forum are available at the B2i Digital event page.
